AGAPE ATP CORPORATION Accumulated Other Comprehensive Income
AGAPE ATP CORPORATION (ATPC) had Accumulated Other Comprehensive Income of -$247.64 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-14
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$247.64K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$28.13K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$14.69K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $12.07K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$247.64K 10-Q · filed 2026-08-14 |
| 2026-03-31 | -$28.13K 10-Q · filed 2026-05-15 |
| 2025-12-31 | -$14.69K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $12.07K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $23.25K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $24.64K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $27.85K 10-K · filed 2026-04-13 |
| 2024-09-30 | $34.11K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $26.89K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $28.66K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $30.21K 10-K · filed 2025-03-31 |
| 2023-09-30 | $17.98K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $11.61K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $11.34K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $9.27K 10-K · filed 2024-04-01 |
| 2022-09-30 | -$31.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $20.22K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $81.38K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $93.40K 10-K · filed 2023-03-31 |
| 2021-09-30 | $86.37K 10-Q/A · filed 2022-07-05 |
| 2021-06-30 | $106.39K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $142.73K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $181.02K 10-Q/A · filed 2022-07-05 |
| 2020-09-30 | $100.55K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $45.60K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $17.55K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $9.79K 10-K · filed 2021-03-31 |
| 2019-09-30 | -$3.39K 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$79.00 10-K · filed 2020-03-27 |
| 2019-03-31 | $4.58K 10-Q · filed 2019-05-13 |
| 2018-12-31 | -$1.29K 10-K · filed 2020-03-27 |
| 2018-09-30 | -$1.29K 10-Q · filed 2018-11-13 |
| 2018-06-30 | -$1.29K 10-K/A · filed 2019-12-02 |
| 2018-03-31 | $340.00 10-Q/A · filed 2018-06-19 |
| 2017-12-31 | $3.74K 10-Q · filed 2018-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |